Langar Global HealthTech ETF (LGHT) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Langar Global HealthTech ETF (LGHT) trades at $10.11 with AI Score 44/100 (Grade C). Langar Global HealthTech ETF (LGHT) is an exchange-traded fund focused on investing in healthcare technology companies globally. Market cap: $4.26M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for LGHT: LGHT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LGHT against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
LGHT: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Langar Global HealthTech ETF (LGHT) Financial Services Profile
Langar Global HealthTech ETF (LGHT) offers institutional investors a diversified investment vehicle targeting the burgeoning healthcare technology sector, emphasizing innovation in telehealth, digital health records, and medical devices while managing risks associated with individual stock performance.
What Is the Investment Thesis for LGHT?
Langar Global HealthTech ETF (LGHT) stands to benefit from several key value drivers in the healthcare technology sector. The global healthtech market is projected to grow at a CAGR of approximately 25% over the next five years, driven by increasing adoption of telehealth and digital health solutions. LGHT's strategy of investing at least 80% of its assets in equity securities positions it to capitalize on this growth. Additionally, the fund's diversified approach helps mitigate risks associated with regulatory changes and reimbursement policies that are prevalent in the healthcare sector. However, investors should remain vigilant regarding the fund's expense ratio and the performance of its underlying holdings, as these factors will significantly influence overall returns. The ongoing evolution of healthcare technology, particularly in response to the COVID-19 pandemic, presents both opportunities and challenges that LGHT will need to navigate effectively.
Based on FMP financials and quantitative analysis
LGHT Key Highlights
Market capitalization of $4.26M indicates the fund's focus on equity securities without limitations on company size.
- Beta of 0.64 suggests a lower volatility compared to the broader market, indicating potential stability.
- No dividend yield reflects the fund's reinvestment strategy focused on capital appreciation rather than income generation.
- The ETF's non-diversified nature allows for flexible investment strategies across various healthcare technology segments.
- Focus on global healthcare technology companies positions LGHT to tap into diverse growth opportunities across multiple markets.
Who Are LGHT's Competitors?
LGHT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| XLV State Street Health Care Select Sector SPDR ETF | $172.39 | -1.87% | $44.3B | 49 |
| VHT Vanguard Health Care ETF | $323.69 | -1.76% | $21.7B | 46 |
| HACK Amplify Cybersecurity ETF | $109.77 | -2.24% | $2.05B | 47 |
| IBB iShares Biotechnology ETF | $210.83 | -2.83% | $10.4B | 47 |
| PJP Invesco Pharmaceuticals ETF | $128.83 | -2.13% | $374M | 47 |
| CNY Market Vectors Chinese Renminbi/USD ETN | $44.25 | +1.96% | $7.63M | 50 |
| LVAFX LSV Global Managed Volatility Fund | $13.28 | -0.38% | $10.6M | 55 |
| WAGSX Wasatch Global Select Fund Investor Class | $12.84 | -0.54% | $12.4M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LGHT's Key Strengths?
Diversified portfolio across various healthcare technology sectors.
- Focus on high-growth areas like telehealth and medical devices.
- Non-diversified strategy allows for flexible investment choices.
- Lower beta indicates reduced volatility compared to the broader market.
What Are LGHT's Weaknesses?
No dividend yield may deter income-focused investors.
- Non-diversified nature could increase exposure to sector-specific risks.
- Market capitalization of $4.26M suggests limited current assets.
- Dependence on the performance of underlying healthcare technology companies.
What Could Drive LGHT Stock Higher?
Continued growth in the telehealth market as healthcare providers expand remote services.
- Increasing adoption of digital health records among healthcare providers.
- Expansion of artificial intelligence applications in healthcare technology.
- Potential regulatory changes supporting telehealth initiatives.
- Rising investments in healthcare technology from venture capital firms.
What Are the Key Risks for LGHT?
Regulatory changes could impact profitability and operational strategies.
- Market volatility may affect the performance of underlying healthtech stocks.
- Competition from other funds could limit market share growth.
- Technological advancements may outpace the fund's investment strategy.
What Are the Growth Opportunities for LGHT?
- Growth opportunity 1: The telehealth market is expected to grow significantly, with projections indicating a market size of $250 billion by 2027. LGHT's investments in telehealth companies position it to benefit from this trend as healthcare providers increasingly adopt remote care solutions, driven by patient demand and regulatory support.
- LGHT's focus on companies developing innovative electronic health record systems allows it to capitalize on the increasing need for efficient patient data management and interoperability among healthcare systems.
- LGHT's investments in medical device manufacturers enable it to tap into this growth, particularly in areas such as wearable health technology and remote monitoring devices.
- Growth opportunity 4: Artificial intelligence in healthcare is expected to see substantial growth, with a projected market size of $36 billion by 2025. LGHT's strategy may include investments in AI-driven healthtech companies that enhance diagnostic accuracy and operational efficiencies, positioning the fund to leverage this transformative trend.
- Growth opportunity 5: The global healthtech market is witnessing increased investment from venture capital, with over $20 billion invested in 2021 alone. LGHT's diversified portfolio allows it to capture emerging opportunities in innovative startups, which are often at the forefront of healthtech advancements.
What Are LGHT's Competitive Advantages?
- Diversified portfolio reduces risk associated with individual stock performance.
- Focus on a rapidly growing sector provides a competitive edge in investment opportunities.
- Non-diversified strategy allows for flexible investments across various market segments.
- Expertise in healthcare technology enhances the fund's ability to identify high-potential investments.
- Global reach enables access to a wide array of healthcare technology companies.
What Does LGHT Do?
Langar Global HealthTech ETF (LGHT) is an exchange-traded fund that primarily invests in equity securities, allocating at least 80% of its total assets to stocks and American Depository Receipts (ADRs) of healthcare technology companies. Established to capitalize on the rapid advancements in health technology, LGHT seeks to provide investors with exposure to a diverse array of companies that are shaping the future of healthcare. The fund operates as a non-diversified entity, meaning it does not limit its investments based on the market capitalization of the companies it targets. This flexibility allows LGHT to invest in both established firms and emerging players within the healthtech sector, which includes telehealth services, digital health records, and innovative medical devices. With a focus on global markets, LGHT's investment strategy encompasses companies traded on exchanges in the United States and internationally. The fund's diversified portfolio is designed to mitigate risks associated with individual stock performance, providing a balanced approach to investing in a rapidly evolving industry. As the healthcare technology sector continues to grow, driven by increasing demand for digital health solutions and advancements in medical technology, LGHT positions itself as a key player in this dynamic market.
What Products and Services Does LGHT Offer?
- Invests primarily in equity securities of healthcare technology companies.
- Allocates at least 80% of total assets to stocks and ADRs.
- Focuses on telehealth, digital health records, and medical devices.
- Operates as a non-diversified fund, allowing flexibility in investment choices.
- Targets companies traded on exchanges in the U.S. and internationally.
- Aims to provide exposure to the growth potential of the healthtech sector.
How Does LGHT Make Money?
- Generates returns through capital appreciation of equity securities.
- Invests in a diversified portfolio to mitigate risks associated with individual stocks.
- Focuses on sectors within healthcare technology that are experiencing rapid growth.
- Utilizes a non-diversified investment strategy to capitalize on a wide range of opportunities.
- Reinvests any capital gains rather than distributing dividends to investors.
What Industry Does LGHT Operate In?
The healthcare technology sector is experiencing rapid growth, driven by advancements in digital health solutions and increasing demand for telehealth services. The global healthtech market is projected to reach $500 billion by 2028, growing at a CAGR of approximately 25%. LGHT operates within this expanding landscape, competing with other asset management firms that focus on healthtech investments. The competitive landscape includes both traditional asset managers and specialized healthtech-focused funds, highlighting the importance of strategic positioning and differentiated investment strategies to capture market share.
Who Are LGHT's Key Customers?
- Institutional investors seeking exposure to healthcare technology.
- Individual investors interested in diversified healthtech investments.
- Financial advisors looking for innovative investment options for clients.
- Pension funds and endowments aiming to diversify portfolios with growth potential.
- Wealth management firms focusing on sector-specific investment strategies.
Key Financial Metrics
Return on equity for Langar Global HealthTech ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. LGHT trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
How Langar Global HealthTech ETF Is Valued
Langar Global HealthTech ETF carries a market capitalization of $4.26M, placing it in the micro-cap category. Relative to its peer group, LGHT's quantitative score of 44/100 is roughly in line with the peer average of 47/100.
LGHT Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Langar's long-term growth potential, indicating that those closest to the company believe in its future.
- Community sentiment has shifted positively, with discussions highlighting innovative health tech solutions that the ETF is focusing on.
- Increased attention on healthcare technology due to recent global health challenges could drive more investors towards health-focused ETFs like LGHT.
- The ETF's diversified holdings in emerging health tech companies may attract investors looking for growth in a rapidly evolving sector.
Bear Case
- Concerns about market volatility in the tech sector have led to cautious sentiment among traders, impacting the ETF's appeal.
- Recent discussions indicate skepticism about the sustainability of growth in health tech, with some investors questioning valuations.
- Insider selling activity has raised red flags for some investors, suggesting a lack of confidence among management.
- The overall economic climate and potential regulatory changes in healthcare may create uncertainty, causing hesitation among potential investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
LGHT Latest News
No recent news available for LGHT.
LGHT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LGHT.
Price Targets
Wall Street price target analysis for LGHT.
LGHT MoonshotScore
What does this score mean?
The MoonshotScore rates LGHT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
What Investors Ask About Langar Global HealthTech ETF (LGHT) — Financial Services
What does the AI Score mean for LGHT?
LGHT holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Langar Global HealthTech ETF (LGHT) is an exchange-traded fund focused on investing in healthcare technology companies globally. The fund aims to provide exposure to the rapidly growing healthtech …
What does Langar Global HealthTech ETF do?
Langar Global HealthTech ETF (LGHT) is an exchange-traded fund that primarily invests in equity securities of healthcare technology companies. The fund allocates at least 80% of its total assets to stocks and American Depository Receipts (ADRs) of firms involved in telehealth, digital health records, and medical devices, providing investors with exposure to the rapidly growing healthtech sector.
What are the main risks for LGHT?
Langar Global HealthTech ETF faces several risks primarily associated with the healthcare technology sector. Regulatory changes could significantly impact profitability and operational strategies, while market volatility may affect the performance of the underlying healthtech stocks. Additionally, competition from other healthtech-focused funds could limit market share growth, and technological advancements may outpace the fund's investment strategy.
How does LGHT mitigate risks associated with individual stock performance?
LGHT mitigates risks associated with individual stock performance through its diversified portfolio strategy. By investing in a wide range of healthcare technology companies, the fund reduces the potential negative impact of any single company's poor performance on overall returns. This approach allows LGHT to capitalize on growth opportunities across various segments of the healthtech sector while managing exposure to sector-specific risks.
What are the key factors to evaluate for LGHT?
Langar Global HealthTech ETF (LGHT) holds an AI score of 44/100 (low). Langar Global HealthTech ETF (LGHT) stands to benefit from several key value drivers in the healthcare technology sector. Not financial advice.
How frequently does LGHT data refresh on this page?
LGHT's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven LGHT's recent stock price performance?
Langar Global HealthTech ETF (LGHT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified portfolio across various healthcare technology sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LGHT overvalued or undervalued right now?
Langar Global HealthTech ETF (LGHT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research LGHT before investing?
Before investing in Langar Global HealthTech ETF (LGHT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The fund's market capitalization is currently $0.00B, indicating limited current assets.